Jan N. Jakobsen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma.

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma.

Journal: International journal of molecular sciences

Published: November 06, 2021

Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.

Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.

Journal: Cancers

Published: April 19, 2019

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment.

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment.

Journal: Oncotarget

Published: February 19, 2018

Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients.

Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients.

Journal: Journal of neuro-oncology

Published: September 14, 2017

Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer.

Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer.

Journal: Journal of cancer research and clinical oncology

Published: October 17, 2013

Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer.

Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: August 23, 2013

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.

Journal: Cancer chemotherapy and pharmacology

Published: June 20, 2013

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer.

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer.

Journal: Histopathology

Published: April 09, 2013

Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer.

Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 19, 2012

Clinical impact of ki-67 labeling index in non-small cell lung cancer.

Clinical impact of ki-67 labeling index in non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 12, 2012

Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer.

Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: September 13, 2011

Irinotecan and bevacizumab in recurrent glioblastoma multiforme.

Irinotecan and bevacizumab in recurrent glioblastoma multiforme.

Journal: Expert opinion on pharmacotherapy

Published: March 10, 2011

Showing 1-12 of 13

Last Updated: 09/26/2026